81 related articles for article (PubMed ID: 38654165)
21. Cuproptosis- and m6A-Related lncRNAs for Prognosis of Hepatocellular Carcinoma.
Zhu Y; Tan JK; Goon JA
Biology (Basel); 2023 Aug; 12(8):. PubMed ID: 37626987
[TBL] [Abstract][Full Text] [Related]
22. Effect of infiltrating immune cells in tumor microenvironment on metastasis of hepatocellular carcinoma.
Chen Y; Zhou Y; Yan Z; Tong P; Xia Q; He K
Cell Oncol (Dordr); 2023 Dec; 46(6):1595-1604. PubMed ID: 37414962
[TBL] [Abstract][Full Text] [Related]
23. Creation of a Prognostic Model Using Cuproptosis-Associated Long Noncoding RNAs in Hepatocellular Carcinoma.
Yang L; Jia X; Fu Y; Tian J; Liu Y; Lin J
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373132
[TBL] [Abstract][Full Text] [Related]
24. Targeting oral tumor microenvironment for effective therapy.
Budi HS; Farhood B
Cancer Cell Int; 2023 May; 23(1):101. PubMed ID: 37221555
[TBL] [Abstract][Full Text] [Related]
25. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
Zhang Y; He D; Liu J; Wei YG; Shi LL
World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
[TBL] [Abstract][Full Text] [Related]
26. Cuproptosis: mechanisms and links with cancers.
Xie J; Yang Y; Gao Y; He J
Mol Cancer; 2023 Mar; 22(1):46. PubMed ID: 36882769
[TBL] [Abstract][Full Text] [Related]
27. Construction and systematic evaluation of a machine learning-based cuproptosis-related lncRNA score signature to predict the response to immunotherapy in hepatocellular carcinoma.
Lu D; Liao J; Cheng H; Ma Q; Wu F; Xie F; He Y
Front Immunol; 2023; 14():1097075. PubMed ID: 36761763
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding RNA polymorphisms and hepatocellular carcinoma and pancreatic cancer risk.
Abdi E; Latifi-Navid S
Per Med; 2023 Mar; 20(2):193-200. PubMed ID: 36705078
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma.
Li D; Jin S; Chen P; Zhang Y; Li Y; Zhong C; Fan X; Lin H
Front Immunol; 2022; 13():991604. PubMed ID: 36685508
[TBL] [Abstract][Full Text] [Related]
30. Cuproptosis related genes associated with Jab1 shapes tumor microenvironment and pharmacological profile in nasopharyngeal carcinoma.
Wang L; Wang D; Yang L; Zeng X; Zhang Q; Liu G; Pan Y
Front Immunol; 2022; 13():989286. PubMed ID: 36618352
[TBL] [Abstract][Full Text] [Related]
31. Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis.
Chen Q; Sun T; Wang G; Zhang M; Zhu Y; Shi X; Ding Z
Dis Markers; 2022; 2022():3265212. PubMed ID: 36452343
[TBL] [Abstract][Full Text] [Related]
32. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer.
Bai Y; Zhang Q; Liu F; Quan J
Front Immunol; 2022; 13():1027449. PubMed ID: 36451815
[TBL] [Abstract][Full Text] [Related]
33. Copper homeostasis and cuproptosis in health and disease.
Chen L; Min J; Wang F
Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
[TBL] [Abstract][Full Text] [Related]
34. Construction of cuproptosis-related lncRNAs/mRNAs model and prognostic prediction of hepatocellular carcinoma.
Tang L; Wang T; Li W; Yu S; Yao S; Cheng H
Am J Cancer Res; 2022; 12(10):4693-4707. PubMed ID: 36381337
[TBL] [Abstract][Full Text] [Related]
35. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characterization in ovarian cancer.
Zhang J; Lu M; Xu H; Ren F; Zhu L
Cancer Cell Int; 2022 Oct; 22(1):328. PubMed ID: 36307842
[TBL] [Abstract][Full Text] [Related]
36. A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma.
Chen S; Liu P; Zhao L; Han P; Liu J; Yang H; Li J
Front Immunol; 2022; 13():954653. PubMed ID: 36189204
[TBL] [Abstract][Full Text] [Related]
37. Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma.
Zhang Q; Huang Y; Xia Y; Liu Y; Gan J
Clin Exp Med; 2023 Oct; 23(6):2051-2064. PubMed ID: 36153416
[TBL] [Abstract][Full Text] [Related]
38. A novel prognostic index of stomach adenocarcinoma based on immunogenomic landscape analysis and immunotherapy options.
Xue W; Dong B; Wang Y; Xie Y; Li P; Gong Z; Niu Z
Exp Mol Pathol; 2022 Oct; 128():104832. PubMed ID: 36122795
[TBL] [Abstract][Full Text] [Related]
39. Cuproptosis-related lncRNA predict prognosis and immune response of lung adenocarcinoma.
Wang F; Lin H; Su Q; Li C
World J Surg Oncol; 2022 Sep; 20(1):275. PubMed ID: 36050740
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy.
Hashemi M; Moosavi MS; Abed HM; Dehghani M; Aalipour M; Heydari EA; Behroozaghdam M; Entezari M; Salimimoghadam S; Gunduz ES; Taheriazam A; Mirzaei S; Samarghandian S
Pharmacol Res; 2022 Oct; 184():106418. PubMed ID: 36038043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
